MGPI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MGP Ingredients Inc (MGPI) is not a strong buy for a beginner, long-term investor at this time. The company is facing significant industry headwinds, as reflected in its lowered 2026 guidance and declining revenue trends. While analysts have mixed views, with some maintaining Buy ratings, the overall sentiment leans cautious. The lack of strong positive catalysts, recent insider selling, and weak financial performance make this stock more suitable for monitoring rather than immediate investment.
The technical indicators show a neutral to slightly positive trend. The MACD is above 0 and positively contracting, while the RSI is in the neutral zone at 59.253. Moving averages are converging, indicating no clear directional momentum. The stock is trading near its pivot level of 17.932, with resistance at 19.002 and support at 16.863.
Hedge funds have significantly increased their buying activity, up 203.87% over the last quarter. Analysts from Roth Capital and Benchmark see potential long-term value in the company's Branded Spirits portfolio and improvement in its Ingredients business by 2027.
Insider selling has increased by 431.07% over the last month, signaling potential lack of confidence from management. The company's 2026 guidance indicates another challenging year, with no immediate signs of year-over-year improvement. Revenue dropped significantly by -23.50% YoY in Q4 2025, and gross margin also declined by -15.29% YoY.
In Q4 2025, revenue dropped to $138.3 million (-23.50% YoY), while net income improved to -$133 million (+220.47% YoY). EPS also increased to -6.22 (+225.65% YoY). However, gross margin dropped to 34.89% (-15.29% YoY), indicating operational challenges.
Analysts have mixed ratings. TD Cowen and Roth Capital lowered their price targets to $22 and $32, respectively, citing weak 2026 guidance. Benchmark initiated coverage with a Buy rating and a $35 price target, highlighting potential recovery in 2027. Overall, the sentiment is cautious, with some optimism for long-term recovery.
